Elite Pharmaceuticals Inc (ELTP)

[Couch]

Anytime you find a CEO like Nasrat running a penny stock company with a previous 30 year history of working in the Big Leagues such as Alpharma and Watson and then with a VP position at Actavis you best buy as many cheap seatS as you can fast!!!

From .068 to .177 and about to file a 100 million dollar generic OxyContin Anda PLUS the FDA has given Elite the GREEN LIGHT on their BRANDED IR ADT opioid!!!

FOLKS its ALL OVER except the CRYING!!!! LOL LOL

Elite Provides Update On SequestOx™ New Drug Application
NORTHVALE, N.J., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the Company met with the U.S. Food and Drug Administration (the "FDA") on December 21, 2016 for an end-of-review meeting to discuss steps that Elite can take to obtain approval of SequestOx™. Based on the FDA response, the Company believes there is a clear path forward to address the issues cited in the July 14th Complete Response Letter ("CRL"). The FDA will provide minutes of the meeting by the end of January and the Company will issue a further update at that time.

SequestOx™ (oxycodone hydrochloride and naltrexone hydrochloride) is Elite's investigational abuse-deterrent opioid candidate for the management of moderate to severe acute pain where the use of an opioid analgesic is appropriate. The proposed plan submitted by the Company addresses items cited in the CRL dated July 14, 2016 for the New Drug Application (the "NDA") for SequestOx™.

"We are extremely pleased that there is a path forward to seek FDA approval of SequestOx™," said Nasrat Hakim, President and CEO of Elite. "Based on the guidance received from the agency, Elite will begin to execute the proposed plan immediately."